AZD0120 for scleroderma, systemic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Dec 2025: Trial registered, NCT07295847
  2. 9 Jan 2026: Trial started, NCT07295847

The trials

NCT07295847: A Study of AZD0120 in Autoimmune Diseases

State
Under way
Phase
Phase 1 and Phase 2
People
27 planned
Started
9 Jan 2026
Primary completion
22 Feb 2028
Arms
AZD0120 Regimen 1
Results
None posted
  1. 22 Dec 2025: Trial registered
  2. 9 Jan 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.